Free Access
Reprod. Nutr. Dev.
Volume 41, Number 6, November-December 2001
Page(s) 505 - 511


  1. Bollengier F., Hooghe R., Velqueniers B., Mahler A., Vanhaeslst L., Hooghe-Peters E., Further characterization of rat 26,000 prolactin as a glycoprotein with essentially O-linked carbohydrate chains, J. Neurosci. 3 (1991) 375-381.
  2. Brue T., Caruso E., Morange I., Hoffmann T., Evrin M., Gunz G., Benkira M., Jaquet P., Immunoradiometric analysis of circulating human glycosylated and non glycosylated prolactin forms: spontaneous and stimulated secretions, J. Clin. Endocrinol. Metab. 75 (1992) 1338-1334.
  3. Clapp C., Sears P.S., Russell D.H., Richards J., Levay-Young B.K., Nicoll C.S., Biological and immunological Characterization of cleaved and 16K forms of rat prolactin, Endocrinology 122 (1988) 2892-2898.
  4. Gambino G., Beck-Peccoz P., Borgato S., Faglia G., Spada A., Persani L., Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions, Pituitary 2 (1999) 225-231.
  5. Gerres S., Hoffmann B., Investigation on the role of progesterone in the endocrine control of overt pseudopregnancy in the bitch: application of an antigestagen and effects on corpus luteum function, Anim. Reprod. Sci. 35 (1994) 281-289.
  6. Gobello C., Baschar H., Castex G., de la Sota R.L., Goya R.G., Diestrous ovariectomy: a model to study the role of progesterone in the onset of canine pseudopregnancy, in: Concannon P.W. et al. (Eds.), Advances in Reproduction in Dogs, Cats and Exotic Carnivores, Reproduction, suppl. 57, 2001, pp. 55-60.
  7. Gobello C., de la Sota R.L., Goya R.G., Study of the changes of prolactin and progesterone during dopaminergic agonist and placebo treatments in pseudopregnant bitches, Anim. Reprod. Sci. 66 (2001) 257-267.
  8. Gobello C., de la Sota R.L., Goya R.G., A review on canine pseudocyesis, Reprod. Domest. Anim. 36 (6) 283-288.
  9. Grunau B., Investigation on the treatment of pseudopregnacy in the bitch with the prolactin inhibitors metergoline and bromocryptine, Inaug. Dissert. Tierarztliche Hochschule Hannover, 1994, p. 105.
  10. Harvey M.A., Cauvin A., Dale M., Lindley S., Ballabio R., Effect and mechanism of the antiprolactin drug cabergoline on pseudoprenancy in the bitch, J. Small Anim. Pract. 38 (1997) 336-339.
  11. Harvey M.A., Dale M.J., Lindley S., Waterson M.M., A study of the aetiology of pseudoprenancy in the bitch and the effect of cabergoline therapy, Vet. Rec. 17 (1999) 433-436.
  12. Hoffmann B., Hoveler R., Hassan S.H,. Failing K., Ovarian and pituitary function in dogs after hysterectomy, J. Reprod. Fertil. 96 (1992) 837-845.
  13. Jackson R.D., Worstman J., Malarkey W.B., Characterization of large molecular weight prolactin in women with idiopatic hyperprolactinemia and normal menses, J. Clin. Endocrinol. Metab. 61 (1985) 258-264.
  14. Larrea F., Villanueva C., Cravioto M.C., Escorza A., del Real O., Further evidence that big big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function, Fertil. Steril. 441 (985) 25-30.
  15. Lawler D.F., Johnston S.D., Keltner D.G., Ballam J.M., Kealy R.D., Bunte T., Lust G., Mantz S.L., Nie R.C., Influence of restricted food intake on estrous cycle and pseudopregnancy in dogs, Am. J. Vet. Res. 60 (1999) 820-825.
  16. Lewis U.J., Singh R.N.P., Sinha, Y.N., Vander Laan W.P., Glycosilated human prolactin, Endocrinology 116 (1985) 359-363.
  17. Mialot J.P., Lagneau F., Chaffaux S., Badinand F., Inhibition de la lactation de la pseudogestation chez la chienne par la bromocryptine, Recl. Méd. Vét. 157 (1981) 351-365.
  18. Mittra I., A novel cleaved prolactin in the rat pituitary. Biosynthesis characterization and regulatory control, Biochem. Biophys. Res. Commun. 95 (1980) 1750-1759.
  19. Okkens A.C., Dieleman S., Kooistra H.S., Bevers M., Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline, J. Reprod. Fertil. Suppl. 51 (1997) 295-301.
  20. Olschewski C., Die lactatio falsa der Hunden: Klinische und hormonanalystiche Unterrsuchungen unter besonderer Berucksichtinung einiger Therapieverfahren, Inaugural Dissertation, Justus-Liebig University, Gieben, 1987, p. 159.
  21. Pankov Y.A., Butnev V.Y., Multiple forms of pituitary prolactin. Glycosilated form of prolactin with enhanced biological activity, Int. J. Protein Res. 281 (1986) 11-123.
  22. Reimers T.J., Phemister R.D., Niswender G.D., Radioimmunological measurement of FSH and prolactin in the dog, Biol. Reprod. 19 (1978) 673-679.
  23. SAS Institute Inc., SAS/STAT® . User's guide, Version 6, Fourth Edition. SAS Institute Inc, Cary, NC, 1989, p. 189.
  24. Sinha Y.N., Prolactin variants, Trends Endocrinol. Metab. 3 (1992) 100-105.
  25. Sinha Y.N., Structural variants of prolactin: occurrence and physiological significance, Endocr. Rev. 6 (1995) 354-359.
  26. Subramanian M.G., Gala R.R., Do prolactin levels measured by RIA reflect biologically active prolactin? J. Clin. Immunoass. 9 (1986) 42-52.
  27. Wittaker P.G., Wilcox T., Lind T., Maintained fertility in a patient with hyperprolactinemia due to big big prolactin, J. Clin. Endocrinol. Metab. 53 (1981) 863.


Copyright INRA, EDP Sciences